330 results on '"Genre, Fernanda"'
Search Results
2. Marcadores genéticos y séricos relacionados con una rápida progresión clínica de la arteriosclerosis coronaria
3. Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients
4. Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19
5. Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review
6. Osteopontin as a Biomarker in Interstitial Lung Diseases.
7. HLA association with the susceptibility to anti-synthetase syndrome
8. The potential of transcriptomic profiling to predict immune-checkpoint inhibitor (ICIs) response in locally advanced (La) and metastatic urothelial carcinoma (mUC).
9. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome
10. Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis
11. Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
12. Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
13. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
14. Endothelin-1 as a potential biomarker of interstitial lung disease in patients with rheumatoid arthritis
15. IL18 as a severity locus for COVID-19
16. Osteopontin as a biomarker in interstitial lung diseases
17. E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases
18. Influence of MUC5B gene on antisynthetase syndrome
19. Obesity and adipose tissue cytokines in rheumatoid arthritis treated with IL-6 inhibitors: does the route of administration matter?
20. Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases
21. Elevated VCAM-1, MCP-1 and ADMA serum levels related to pulmonary fibrosis of interstitial lung disease associated with rheumatoid arthritis
22. Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients
23. Association of circulating calprotectin with lipid profile in axial spondyloarthritis
24. Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound
25. Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism
26. IgA Vasculitis: Influence of CD40, BLK and BANK1 Gene Polymorphisms
27. Cranial and extracranial large-vessel giant cell arteritis share a genetic pattern of interferon-gamma pathway
28. Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients
29. Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
30. Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients
31. Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?
32. Serum leptin concentration is associated with the attainment of clinical outcomes in patients with axial spondyloarthritis treated with TNF inhibitors
33. Angiogenic T cells in interstitial lung diseases
34. Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines
35. Asymmetric dimethylarginine but not osteoprotegerin correlates with disease severity in patients with moderate-to-severe psoriasis undergoing anti-tumor necrosis factor-α therapy
36. Role of VEGF Polymorphisms in the Susceptibility and Severity of Interstitial Lung Disease
37. Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients
38. Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype
39. The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis
40. Brief Report: Association of HLA–DRB1*01 With IgA Vasculitis (Henoch-Schönlein)
41. Additional file 1 of Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
42. Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome
43. Investigation of a PON1 gene polymorphism (rs662 polymorphism) as predictor of subclinical atherosclerosis in patients with rheumatoid arthritis
44. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
45. Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients
46. Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy
47. Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients
48. Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
49. Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid Arthritis
50. ¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.